Development of 111In-DTPA-human polyclonal antibody complex for long-term inflammation/infection detection

Nukleonika

Volumn 50, Issue 3, 2005, Pages 91-96

  Jalilian, Amir Reza ^a   Rowshanfarzad, Pejman ^a   Shafaii, Kamaleddin ^a   Kamali Dehghan, Mohsen ^a   Moafian, Jamshid ^a   Akhlaghi, Mahdi ^a   Babaii, Mohammad ^a   Rajabifar, Saeed ^a   Mirzaii, Mohammad ^a  

^a ATOMIC ENERGY ORGANIZATION OF IRAN   (Iran)

Author keywords

Human polyclonal antibody; Indium 111; Inflammation; Radiopharmaceuticals; Turpentine oil

Indexed keywords

EID: 27144449659     PISSN: 00295922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Buscombe JR, Oyen WJ, Grant A et al. (1993) Indium-111-labeled polyclonal human immunoglobulin: identifying focal infection in patients positive for human immunodeficiency virus. J Nucl Med 34;10:1621-1625
2. de Kleijn EM, Oyen WJ, Claessens RA, Corstens FH, van der Meer JW (1995) Utility of scintigraphic methods in patients with fever of unknown origin. Arch Intern Med 155;18:1989-1994
3. Eckelman WC, Karesh SM, Reba RC (1975) New compounds: fatty acid and long chain hydrocarbon derivatives containing a strong chelating agent. J Pharm Sci 64;4:704-706
4. Fischman AJ, Fucello AJ, Pellegrino-Gensey JL et al. (1992) Effect of carbohydrate modification on the localization of human polyclonal IgG at focal sites of bacterial infection. J Nucl Med 33;7:1378-1382
5. Fischman AJ, Rubin RH, White JA et al. (1990) Localization of Fc and Fab fragments of nonspecific polyclonal IgG at focal sites of inflammation. J Nucl Med 31;7:1199-1205
6. Hnatowich DJ, Layne WW, Child RL (1983) Radioactive labeling of antibody: a simple and efficient method. Science 220:613-619
7. http://www.docguide.com/dg.nsf/PrintPrint/ 150749630B95133B85256372004AC561
8. http://www.fda.gov/bbs/topics/ANSWERS/2002/ANS01138.html
9. http://www.fda.gov/bbs/topics/ANSWERS/ANS00463.html
10. 111In-labeled genetically engineered Fab' and constructs of chimeric tumor necrosis treatment antibody. Cancer Biother Radiother 18:931-940
11. Kladnik S, Budihna NV, Batagelj I, Gubina M (1997) Separation and technetium labeling of autologous polyclonal immunoglobulin G. Nucl Med Biol 24;6:535-538
12. Lai J, Quadri SM, Borchardt PE et al. (1999) Pharmacokinetics of radiolabeled polyclonal antiferritin in patients with Hodgkin's disease. Clin Cancer Res 5:3315s-3323s
13. 99mTc- HMPAO labelled leucocytes in inflammatory bowel disease. Eur J Nucl Med 22;7:664-700
14. Marczenko Z (1976) Spectrophotometric determination of elements. John Wiley & Sons Inc, New York
15. 111In by irradiation of natural cadmium with deuterons and protons in NRCAM cyclotron. In: Proc on 15th Int Conf on Cyclotrons and their Applications, 14-19 June 1998, Caen, France, pp 65-67
16. Nijhof MW, Oyen WJ, van Kampen A, Claessens RA, van der Meer JW, Corstens FH (1997) Evaluation of infections of the locomotor system with indium-111-labeled human IgG scintigraphy. J Nucl Med 38:1300-1305
17. Oyen WJ, Claessens RA, Raemaekers JM, de Pauw BE, van der Meer JW, Corstens FH (1992) Diagnosing infection in febrile granulocytopenic patients with indium-111-labeled human immunoglobulin G. J Clin Oncol 10;1:61-68
18. Pain SJ, Barber RW, Ballinger JR et al. (2004) Tissue-to-blood transport of radiolabelled immunoglobulin injected into the web spaces of the hands of normal subjects and patients with breast cancer-related lymphedema. J Vasc Res 41;2:183-192
19. Pain SJ, Nicholas RS, Barber RW et al. (2002) Quantification of lymphatic function for investigation of lymphedema: depot clearance and rate of appearance of soluble macromolecules in blood. J Nucl Med 43:318-324
20. 111In-labeled nonspecific immunoglobulin scanning in the detection of focal infection. New Engl J Med 321;14:935-940